Arbutus Biopharma Corp (ABUS) Shareholders’ equity 2016–2025
Arbutus Biopharma Corp (ABUS) shareholders’ equity at each fiscal year-end, per SEC filings.
$76.6MFY2025 · since FY2016: $203.0M → $76.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $76.6M | -21.4% |
| FY2024 | $97.4M | -8.2% |
| FY2023 | $106.0M | -22.5% |
| FY2022 | $136.9M | -19.2% |
| FY2021 | $169.4M | +66.2% |
| FY2020 | $102.0M | +40.2% |
| FY2019 | $72.7M | -63.7% |
| FY2018 | $200.2M | +9.7% |
| FY2017 | $182.5M | -10.1% |
| FY2016 | $203.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice